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COMMISSION  OF  THE  EUROPEAN  COMMUNITIES 
COM(81)  363  fjnal 
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Third' commission  report 'to- .t.he- -ttiunc.·it~-. 
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on  the- .:functioning ·o_f  the. Committe_e  for.-"'Proprietary  Medic·in~t Products 
'  .  :  '  .  '  - ~  ,  .  . - .  i  . 
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I ..  IN1i:fODUCIION 
.".· 
:  - ~  .  * 
-t.,- -.  -C-ouncil  Directive  7~/319/~EC  e,stablishing  the  Commit~ee for  P~o~rie--
t'ary  Medicinal  Products provided,  in  Article  15\'D-,.  that  the  CGmmiss.i.on  / 
. shoul.d  report  to the  Counci't  annually  on _the  op:EH~ation-of that ·committee's 
pro~edure .and  its  impact' on  the development  of  1ntr~~Community,t~a~eo 
Essertti~t~y; the  Committe~is Fr6cedure,makes ·it  possibl~  fo~ the 
hold.~r of  ~-·marketiog- authorii.ation  i.n -9ne:Membea"'  state to  fil-e an .appti~ation 
for  authorization in  respect of. the  same  proprfetary· pr~oduc.t  in  a-t  least .ffve 
/  '  ..  .  -
other  countries  ..  Should  o~e·o:r mo.re'  co.untries ·consid~r that· such authorizat-ion 
cannot  be  grant,ed?  the  objections·. are  submit~~d to -the  Committe.ep  w_h:J ch 
expr~sses  a~non~binding opinionM 
2..  The'  Comrtdttee.' s  settir1g-up  and  running-in period,  in  19.77  and  1978, 
'.  was  the  subject of  an. init.ial  report~*  '  ' 
***  ~During -1979 ,· the-period _¢overed  by  the  Sec<?fld  Re-port  ,  the  Go'mmittee 
meetings  were  t.he  m'eans  of -p_,ro.moting  cooperation· betw.een  t!~e  nat_ion~l authori--- ~ 
-ties, especiatly  in ·the ·field qf  drug  monito~i~g.  Simultaneousl}'~  the 
Commit~ee'  s  three groups of. expert's  were 'pursuing their.  work  on 'the  safety· 
.  \  ' 
a.nd  efficacy of  medicines  and  ~n p lant-b~sed pr9du~ts~~··. 
/' 
· Nevertheless,  by'  the  end of _197~~  the  procedure  had  beeh  used only 
-~wice, ·w-ith:'-two  C~J!fittee ·opin,ions  emerging., 
3~  This Third ~~port  co~~rs the y•ar  198fr  ~nd ~he f~rst half  of·1981~ 
.~n  i~_crea~ing number  of applications involving  the use_of ·the 
Committee
0 s  procedure  were  fi fed  from  the  second  -~at  f. o.f  1980,  but  t'he 
vast majority of  the opin-ions  were  not  adopted·  unt~l 1981" 
.1. 
*  ~  ·  OJ  No  L.  147,  9.6  .• 75· 
**  .t0M(79>S9,  22.2.79 
***  ·. COM(80) 149  i  31.3.80 
.--
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'  /(' 
~w~n~~to ~he nor~al effect of  th~ peri~ds allowed  fo~ the  pro~edureo · 
It was  therefore advisable, to  wai·t  until  1981,  so  as  to have.  a  minimum, 
amount  of 'experience  w-i~h _this  procedure  and  be  able 'to  arrive at  a  first' 
·assessment  of  its functioning.  By  the  end of  1980,~the CommissioA'had  _  , 
. -.already  suppli~d information .on  the status of the  Comrrii~'tee•s procedure.-
and  its inadequa-cies·  in its +report*  to the-Council_ on  th~ atppr.oximation-
.  .  .  * 
,  of  laws  relating to- propriet~.ry medicinal  products.  This  report  ~upport-ed 
proposals**  the  ~ain purpose of  which  is  to  se~ure·~utual  re6dgrtition of 
I  "  ... 
mar~eti_ng· ·authorizations;  i-n  parti cutar ·through ·a  change  in the  Committee•-s-. 
procedure. 
'  . 
4~ - Under  such  circumstances~" assessment, of the procedure• s  spec~ifi·c 
effects  O¥l- the, devel.opment  of  intra"''Community- trade' remains  purposeless  .. 
'  .  ' 
The  statistics  'con-c~rning  the- development  o1  intra-Co_mmunity  trade  in 
medicinal  products ,between 1975  and  1980~ are set out  in  Anne><  I ..  - I 
-.  Intra-Communi-ty  imports of-medicinal- products  account- for-- nearly three-. 
quarters o,f  the  Community's  total  d~ug  i~ports_  ..  It does  not  appear·:· a'$ 
though this .high propo,rtion  can  be  exceeded  ..  A.lmost  two-thi·rds of  exports· 
go  to non-member  ¢ountries.  The  trade balance is in substantial  surplus~ 
a.s  imports  from outside the· Community  amount  to  scaree~y  .a  quarter of. the 
volume  of exports to non-member  countries. 
',*  COM(80)789,  28.11.80 
-. --.--..  I 
.  ' 
*x  .  Proposal_ for  a  Council  Directive amending  Directives 65/65/EEC,  75/318/EEC 
and  75/319/EEC  and  p~oposal for  a  Councit  Recommendation  concerning tests 
relating to the ,placing ·.on  the market of proprietary medicinal products,·. 
OJ  N°  c 355,  31.12.80. 
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. Various· observations- are  call-ed  for  as a result  of -considerat·ion of 
'  \  ' 
·the  S~,JCCe$SiVe  ~tages 1n  the procedure  for  applicat-i,ons  for  mark~t_ing authori- i 
- f  . 
·~ation.,; as  p~ovided in-'Art~icles_ ·9- 1_1  of  Dire.ctive  75/31'9/EEC~ which  were 
-~ade-by·~.Member ·sta~e~_at the  request  of  a  manufacturer~~o at  ~e~st five 
other Member  States. · 
1 ••  FILING  ·oF  APPLICATIONS-
--ea...-*11--:~-~  ... ---..-.  .... ----__  ... _ 
Each ·appl  i-c~ttdn may  relate  t.o  one ·or  mor~ propriet'ary  m'edicin,a~. -- · 
·~rodu~t~  co~taining the  same.active  subst~nce in  severaL  ~h~rmace~t~c~l 
or  dos~gef.orms. 
.., 
The  number~ of  appl  i c~tions_ filed  has  cons1derably  i'ncreasec;t  .sinc-e.  the· · 
second  half of  1980. 
-
I  ,.  '  I 
~  I  ~  .. 
.  Number·  of applications  1978  1979  -1.980 
I. '1980;  1981  TOTAL-
1st half 
I  hal  f.  1st  half  (JUNE  198·1)  ,2nd 
I  ' 
/ 
;:  I  -
F1Ling  o.f ,applications  2  "2  1 
I.  6  5  16 
I 
..  I 
-
I 
Nqmber  of pr_opr i et  9ry  . .  I  28 ·  . 
". 
medicina-L  products  5  2.  3  I  9  '  9  .,. 
~  ,. 
\  '  - I 
- .. 
- J 
,  I 
s·ome' ap~-l fcati'ons  are  ~ccompani  ed  by  vo.Luminous  data·-and  they  reach  the 
various -countries  concerned  only  after_ some.  delay,  which,  in  two  cases 'out  of 
sixteen,_ .has.  ~xceeGfed 45  day~  •.  In  ord~r to. reduce t  .  .his  delay,  th·e. Comm.ittee  h~s 
,.  '  ~  .. 
_,  •  I' 
agreed·t~at the_applicant  can  be  instructed by  the  country  of~origiri  t~ lpdge· 
himself  a- copy/ of ·the  dossier\. with  the  c_our)tries  concerned  and  the  Committee• s-
._·#  ,' 
Secretariat.  -·  '·' 
• I •-
,'1 
.•  . 
.  \ '{ 
I  ' 
-- 4  -
.  '  2.  PRESENTATION·  OF  THE  DOSSIER. 
----~~----~~~----~-~--~-~-~ 
f 
ALL  the.recent dossiers are  in  conformity with  the presentation  scheme 
. r.ecommended  by  the  Committee. 
This  standard presentation exempts  the  applicant  trom  complyi~ with 
~he.various  ~ational  form~ of presentation,  bu~ also,  and  in  particular~ ~t· 
considerably facilitates the Committ·ee' s  proce~dings. 
',/ 
Aoother  appreci~ble  adv~ht~ge of the  Committee's  procedure ii  th~ · 
possibility of -emp toying ·languages  othe·r  than the. national  languCl'ge  for  the 
~os~ voluminous  parts of the· scientific. literat_ure.- IJi  a  notice*  of July  .198~ 
to.  appl fcants,  c'ertain  countries  stated  wh~  ch ·languages they  could  accept.· 
.- T~hus,  in  the. case  of a _.dossier  in  English,  and  even.more  in that of one  in· 
both 'Engli.sh ·and·  Frenl(:h,  only the general  information on. the product,  the 
label ·and  the package  insert  will,  ~s a  gene~al rule,  h~ve to be  transia~ed. 
~This obviates  long,  expensive  ~nd possibly dubious  translations of  some 
thousands of  pages  of  each  dossier. 
LANGUAGES  ""-
~ 
AC'C EPT ABLE  .,.  '  . 
'  ' 
''9.1<·'  . GR  ACCORDIN'G  TO  THE  BE  BRD.  FR  (3)  IR  IT  LUX  NL  UK 
·NOTICE 
ENGLISH 
pharma ceut i cal 
·dossier  ( 1)  +  - +  - +  +  - +  +  + 
~ 
tests  (2)  +  +  +  - +  +  +  +  +  + 
FRENCH  · • 
pharmaceutical 
I 
dossier.(1)  +  - - +.  +  +  - +  +  -
tests  (2~  +  - +  +  +  - ·+  ·+  .. +  -
·' 
I 
GERMAN  ,tYit 
~ pharmaceutical  .+  dossier  ( 1)  +  +  - -·  -.  +  - +  +  .... 
tests  (2)  +  +  +  -
+  ...  - - +  +  -
~1)  Pharmaceutical  dossier:  composition,  method  of  preparati6ri.~nd manufacturer's 
·  control  methods  (Art •. 4C3>;_(4),  <7>, 
. Directiv~ 65/65/EEC) 
(~)  Analytical,  toxtcol~gical and  pha·rmacological  tests_ and  clinjcal trials 
(Art.  4(8),  Directive 65/65/EEC  ·: 
(3)  Particulars provided  by  the ~reek member  of the  Committee •. 
. • I. 
*  OJ  N°  c 162,  2.7.80 
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.New  drug~  ar~  ·g~ner,,afly first introduced in the Uni'ted  Kingdom,- "france. -<  .. }  :· 
.·  aniJ·.Germany.  The ..  Co~-it·te_e'·s--proc,dur·e is _ther_efore  :relati~~Ly  l'itt.~e·-u.sed  . 
v.i·s:..~-v-i.s  these  _thre~ .countr~e~,  wh~~e  _proprietary pr,odu_cts  ar~ genera-lly ...  ·_·.  ··  , 
..  a.lready_  be~ng '!arketed  ~hen ·th~  p~ocedure. is·  initi~ted. Most -of· :-the  _appli c-~~- _  - ~ 
-· tions forwarded' -to  ·the  Cominitttee. have  been--filed ·by  the United' Kingdom  .• 
,·  - .. ·  .  ' '  •  '  .  .  - i -- -- .  - .  -- ' -
-' /.'  · Tois -is· -partly accounted for  b'y  the fact  that' the original particulars  and .. · 
- .  .  ~  '  - \•  ·~  .......  ...._.-- :, 
.·.  ·d9cuments  in  English  ca·n  be·used.dfrectly in.most oft-he'other_ c.ounti·res.<.·--.  ---~  ·-.  ·:;" 
_  .. _ I.t  ~ay·  ·be.obs~rv~d tbat,_ wlh.-reas· the pr:-oeedure -r-equir.es·· that  tne.'·_·a~plicarrt ·. 
_-.  ·~-~licit ·-~t  lea·st  five  State.s, the average ·number  ha-s  hithert~ been  l-ess  than 
""'  six .  (5  .  .-875  to be exact>.- ; 
I  ,  •,  '  - --
_, 
-Out.  of -16 ·-applications 
-





'  Number  <?f ·  ·applications 
'-
int-roduced  by  I  3  1  '  3  0'·  .'0  0.  0  0  0  9 
the  country  -· 
~ '  -
~ 
. 
.Number. of  apJ)l i-cations  12;- 8  '12  7  o.  9.';  10  15  15  6  ·~-
made  tci the  country  -
'  -
,_ 
;  - '  -- ,.  I 
·- ·' 




As  soon  as  receipt of an  application by  a-ll 'the  .c~untries  co~c~rned has'· _ 
_  been  confirm~d,  ··the  COJnmittee' s  Secr,etariat  info'rms  the nati·ORaL author{ties 
by  t-elex-. of tne: commencement ·of the  prescribed-m~xi'mum.period of·  120 .days. for 
\_  ..._  .  .  ', 
· · the subfect of  reasoned- O,~jections within the meanfng  of  Art.i cle 1.0(2)  of. 
'  .- ,..  '  '  "'  - ~ -
Dire_c.:tive  ~5/319/EEC.  u,s~ally such_ objections  come  from  all the  countries to 
.  .  .  -
.whi_ch  the  appticatidns  are. ·sent;  those  m.ade  upon  expiry_ of tbe 120•day 
time-li-mi.t ·are·not· ta-ken "into  accou~t. The- pledge 'tha·t  t'h_is  time-_limi-t '..wi·l·l 
'  '~  '  '  .  ' 
~'be co,Pl-ied ·with  ·;s  an appreci.ablt!' ad,vantage  for manufactu-rers. 
The  C_omnlittee -hope~- that. in future natJonal  author.it-ies wfl,t  make·. a' 
·clear  dist.in~tion betwe'en objections ·of  substance,  which ·require  in-depth:' 
·di-scussion by· the 'Committee,. and ·mere  requests·  for ·clarification .or  · 
.  t inguis_ti c ·amendments,  wtd c,IY. can be  ~ati  sf~  ed throug-h direct .. contact  with..  ·  · 
~app.L  i. cants, before-the  Committee  ~c~va  lly meets. 
~  l  . 't:  '·  ·.'/a·. 
....... 
-~ 
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._  The'Committ~e has. not  yet  been  io  a  position to·  info~m any_Member 
- s~ate that, as provided  i~ Arti ele 10(1)  of Directive 75/319/EEC, .where  no 
objections  have  been  notified, the  MA  applied for  should be  grant~d. 
i:' 
By  ·May  1981  it had delivered eleven  opinio~s within the 60 days  referred- to  ··  · 
I  ',  I 
in Article _11_(1)  of this Directive,. tw~ o_f  them  being. in  1979,  two  in  1980 
and  se.ve·n  si~nce the beginning of 1981 ~ 
Contrary to the  fe·ars ·expressed· by the. pha.rmaceuti eal  industry,  the 
(  '  .. ,  '  ~  "  ' 
Committee·  has .not- aggregated the demands  of a.ll  its members.  So  far  from 
th'is,· it has  be'en  careful  to assume  moderate  .attit~des,  s~curing the with• 
·qrawal ·  o1  many  objections :during ,discussions.  · · \ · 
·\. 
Since· dia.logue  Qetween  the applicant  and  the  Comm.ittee ·has not .yet 
been  provided ·for in the· curre.nt  procedt.tre,  there  remain··a  few  analytical'  · 1 
points· to be\ clarified or  a  few  amendments  to be made  in the genera't  infor·-
.- .  .  \  .  ' 
"  ma~'ion or the package· 'insert.  The: Committee ·mentions·-tt,is  in its opinion 
so  that  a  manufacturer  may  give a  single,  compr_ehensive  reply. 
In the  interests of  companies  conc~rned, it .is  not .possible to quote 
·the names  .of  the medicines  subjected to the procedure.  It may  be  noted, 
howev~r, that  the  Committee  unanimously  decided to adopt  six  favour.able _and·  .  .  ~ .  '  -
two  unfavourable opinions.  The  unfavourabte opinions  were  due ·to  .inadeq~acies 
'  . 
in  t·p.e  files  as  re~ards proof of the harmlessness .and  efficacy .of the drugs. 
Three other  favC!urable  .opinion's  were  adopted  by,  the maj ori~y of  the 
Cornlllitte~ members;  one,  three  and  four  Committee .members  r-espectively were 
not wholly satisfied with  the documents·and particulars submitted. 
6.  ACTION  TAKEN  ON  THE  COMMITTEE'S  O~INIONS 
---~----------~---.---.--.....  ----------------~~ 
It ·is  mandat·ory  for  the· Member  States to state their posit·i'ons within 
30 days of  re~eiving the Committee's opinion  •. 
- -
More  _often  than  not  they 'have,  within this snort  time~~  imit, only· been 
able to  inform .the  C~ittee th~tthey were  prepar1ng_to  COfl!Ply·  with the 
opinion expressed.  Authorization can  then be.  granted only .when  the manufacturer  , 
... 
' .  ·'·  .  I· 
.... 
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zn·:tne  shOrt  term there  is. no  prospe~t o.f  .~·he  texts: of national' ·  ..  ..  '  .  "  '  \  , .:  ,'  ·' 
pack~e leaflet·s being  standar~i%eCf,  · even· i·f agreemen-t· can be  obtained in 
.  '  •  '  '  .  •  - .  •  '>  .........  .  •  •  '  -·  •  I. 
the~·-Coanittee _on  the Min  indication~ or· other ~ssential d~ta of··authori•· · 
· ·zati()n  •. 
,... 
. •  In  ~the case-- ~a. rarer ()C-currence  - of a ·proposal :to refuse a  p.roduet, 
the manufac.tur_er  mOst-be_  given the opportun'ity  ~o exhau~t all  the_p~ss:ibili..;.; 
.  tii!s  offer~d by  appe·al .pro.ceedings at ·ri~ti~nal· level.; .which  are ~ften  .. ·  ·.  · 
long~drawn-out·.·. The.'Co~it-tee keeps  its~l  f  regula-rly.  i.nfo:rm~d ~f the. ,sub-
·-'·seque~t  de·v~lopment  -~f-_the ·proce9tJre  at  nati~nal. leve~  •  .The  C9mi$~ion,· 
'  '  - -..,  •'  '  -r  '  ~  '  •- ~  '  •  ~ 
1Qr  its part·~ watche·s  ver'y  closety. thi·s  stage of the  implementation of  th'e · 
Committee's opinjons ._in  ·order- to prevent  unwarranted  ·.d,l~ys. 
' ..  ..._' 
T~e  / Comtnittee  has.  also. expre.ssed the wish that any  subs:t'anti.a(  ch'anges 
m·ade  ~n the file'  once~.  the pr~~Oct  has··b~en.  auth~rized be  b_rought  to its·: 
.-notice'-either 'by~ the'  manufacture~ or .by  the na,tiorial' authoriti'es  in  o.r~er.,  -. 
as tar  as  poss~ble, to keep  a  single filt: .for each  of the p~oprietary Products 
,in  respect  of-.w~i  cb.  the  Commit tee  • s  ~procedure has .be.en ·followed. _ 
- '  . 
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ll'!; ·toOPERATlON  WITH-IN  THE  -COMMITTEE  .. 
1. uENERAL  _  .........  __  I 
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· ·  Cooperatio~ between  the nat;onal authorities throUgh  t~e instrumen't·a-· .\  .. ,  .  ·.  ·l! I 
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~l ity_  .. pf  the representati·ves within the Committee  for Proprtetary Medicinal  .  1 
'•  .  r  .  .  ,  ~ 
Products,continues to  int.ensi.fy  ..  Among  the  subject·s dealt·wit'h are  streng-~~- ..  ·~ 
I  '  ., 
thening  of: the  information exchange  system, drug monitoring,  fotlow.,.up  of 
.  _,.  '  '.  - /  '  . 
the  work. of the J)anels of experts, and  certain views  co~cerni:ng .the 
,l  ,' 
implementation of the Directives• 
•  J, 
The  Committee  for Proprietary Medicinal  Products  held  six meetings  in· 
'~  ~·  ~· 
19SO,  namely,  on  24  Jlinuary,  4 ..  · 5  March,  2  April,  13 - f4  May,,: 9  -~eptember  -,  - -:- '  '  -
and  11  - 12  November.  During  the first half of 1981  ~he Co~ittee met  three 
times,  i~e~.,  on  'tO·- 11  ·february,  10 - 11  March and  11.-- 12  May. 
There  have  been  some  changes-. -.in  the. member~hip of the Committee.-
~he ·oani sh  representatives  are  !'lOW  ~r ANDERSEN_,· member,  and  M·rs·: KYLLINGSBAEK,  '· 
. deputy,,while the· French  representatives are Mr  GRECH,  member,  and 
·~  . 
Professor'·  ALEX-~NDRE,  deputy.  P·rofessor STILLE- has been  appointed the· German 
. representa-tive• s  deputy. 
·.  ·  ··Gr~ece -has,  appoint~~ as its repre·sentat1ves  ~n tt_\e  Comm~_~tee Professor _.VARO_Nos·,. 
- member,  and Mrs  MELI~·SARATOU,  depu~y. 
A  list of the present  members  of the CoMittee ·is given in Annex  I~  •  .  '  '..., 
'  J 
2.  INFORMATION  EXCHANGE  SYSTEM 
~ --------------~---.  ..  --------------.-..-
The  exchange of-information on medicines  p_rovided  for  by  Di'rec~-ive . 
75/319/EEC  has ·increased.; _Very  simple procedures  have been -introduced. in' order·· 
to optimize. the use of this info'rmation,  without  forcing either g·overtiment 
-_departments or  the Comm.i.ssion  to create new  instru~nents for this purpose. 
Pursuant to Article 33 of Directive  75/319/~Et, •ll national  measu~es 
•  •  ;1110--. 
relating to market.jng  authorizations for  medicines  must  ·t:»e  bro~hf to the- ·  .. 
j'..  \  •  •  - I  t  -
attention of the  Co~ittee immediately.  The  common·notification form  '' .· 
- . 
· C"cf.  Annex·  III>  recommended  by the Cof!l"littee  has  ~een emp-loyed  by all 
-,,  I 
Member  States. si!"-te  Jul_y  1980. It enables the Comraittee' s ·secretariat 
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to pas.s ·on  t_o  nat.ional. •uthorities  th~ most  impof:'tant  data·· reportet -by. a 
'  - •,  ..  ;  ,I_  '.  '1.  ' 
.M~inber··s~_~te·:  new  d~~s- Cst,bstance·,  dosage·':  new  fo.rm  or ·in.di-ca.tiof:ls>;  ·-'~ 
refusals, cases- of  prohib~t'ion of  a  proprietary med}cina'L  ,produc-~  ~nd its  .·  ·  · 
wi·thdrawal  from  the- market~  Up  to now,  approxi!'tately 2  000  forms  of this 
~  - '  ;  ~  I 
~  .  '  -
. -,type  have  be~n~ sent  in to  the~ ~omrn'ittee,  whi'c:~, has ·forwarded  apout  8.00  to . 
~  th~  app~opr.i  a~e government:· departments.  Fur-thermore,  this- in1ormation·. is .,  · · 
,-used  by. the· .covn"i l  of  Europe, for the purpose of  updating  Resolution  AP  -C17) 1  ~  ·· 
. · on  drugs  subject to medi'ca l  prescript  ion. - . 
\  '  - . 
A l.ist .Of  national  e-orrespondent$  <Annex  lV>,  which is regylarly 
'updated, has  been  dra~n.up -to  permit' ·rapid  excharyg.~ of ·ac.cu'rate -information  -~-
·.  '  '  .  ·in the following  fiel~s: 
..J  decisions 'authorizing marketing-(Article 33,  Directive 75/319/EEC>;· 
·- withdrawal  O·f  batches,  p~ohibition of supply  (Article- 28, 
Direc~ive 75/319/EE~); 
I-
man~facture, .inspection (Article 30,  Directive  75/319/~EC>; 
· --drug  mot;litoring  CArti cl-es -12  and  14,  Directive 75/319/EEC). 
Certain  m~dici~es  h~v·e .been  the :subject of  spe·cial  discussion by  tne, · 
·Committee,  which  has  reviewed their quality,  safety or ef.ficacy.  Without  •.-
- ,  .  '  I  \  , 
formally  refer.~ing to Articles  12  or 14  of ·oirecti·ve 75/319/EEC,  Commi.ttee  -· 
members·  have  formed  the  habit of  t:"~is·ihg  topical. q~estions or presenting 
measures  which  their na·tionat. authorities  contemplate  adopti(l9· 
More  ~articularly, the  following  active principles have  been dealt 
with:  a-ristolochid acid;  clioquinol;  clonidine; dicycloverine;--dinoprost; 
din~prostone; difemerine  furazolidone; Haemoresin  (R);  Lynoestrenol;-:-· 
medroxyprogesterone;  methapyrilene; .nalidixic acid;  noramidopyrine; 
oxetoron~;- s~lfinpyrazone;··tienilic ~cid; -tipepidine;  triazolam;  valproic-
acid.  Urgent measures  taken! at national  level  can  be  immediately  communicated. 
t~ the  correspondents mentioned above. 
·,., 
.  / .. 
,. 
,  .,.~I 
•  -.,  I,' 
/ 
·~  '  .•. 
.•J-·  . 
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Pursuant 'to -Article 13  of· its .ruLes of .procedure~ the ·Committee  set-· 
up  three ·panels of  .e.Mp·ert:s~ 
-· 
The  Working  Party on  Medi  .. cinal Products 
1of: Pla·nt  o·~igif1,  Gha1r-ed  by 
. Professor· S(H~IEDER·S,  has  n<!t  met  since 1979  as  it· is -awai·ting  ·tb~ r:esults 
of studies being ·carried out  at ·national  level, not·ably  in Germany. 
.  (  .· 
The  Worki-ng  Party on the  Safety· of  Drugs,  cha1r~d by  Dr.  GRIF~IN., · . 
~~completed~  its work  in ·December .1979  and· its proposals  have·.~een incorporat-ed· 
tn the  abovementioned proposal  f.or  a  Council. Recommendation of 4 ·oecember  1980. 
· Neverth~less, it met  on 9  June  1980 to  rf!vise. the. project  r-elating  t·o-
. mut~geni  c  potenti·a·l,  which  will .be  formally  submitted ·when  the· proposal  for · 
j  :·  '  '  '  '' 
incl~ding thf.!  ~utagenesi.s_ test in Directive 75/318/EEC  has been  adopted by· 
the council. 
The·  W9rk:ing·  Party on  the Efficacy of  Drugs,  chaired by  Dr  DUKES,  met 
four _times  in: 1980, .. e.e;.,  on -11  - 12  February,  21  - .. 22  Apri t, 16  - 17  June 
.and 29-30 September  and  once during.the  firs~ half of  1981~  namely~ on 
22  -;- 23  June., 
'The draft  concerning  fixed  combinations/of drugs  has  been  incorporated-in·the. 
proposal  for  a  Re~ommeridation of  4  December  .1980.t 
The  siudies  concerning  cardiac glycosides  ~nd oral  contraceptives  have  b~en 
comp let~d. Considerable di f,fe-rences  of opi.rlion  have  emerged  regardin,g" the 
•  ,  r  •  •  , 
clinical trials which  have  ~o be  ca·rri~d out  inthe ca·se  of drugs  intended 
for· use  in  long-term treatment,  such as nonsteroid  anti•inf~lammatory ,agents, 
··anti epileptics and  antianginal agents.  The  status of the  wor'k  o.f  this-panel·  '" 
is p~ese~ted in a  table,  ~hich appears· in  Annex  v. 
·  The  consultation prptedures  are far  advanced.  The  main  obfect of  t~e 
work  of_ the  Committee's experts is  to try to  avoid; _in_  some  fiel.ds ·which 
have  pri~rity, differences  in ,the  imp lementatio,n ~by the national  authorit·i es ,·  r. 
of the prov1si_ons  of Directive 75/3.18/EEC,  which  r~late to. th~ ·standards and. 
procedures_  fn  r'espect of the testing of medi·cines.  Thfs  work ··entails  a  very _ 
onerous/ consultatio.n procedure,  wh.ich  it i.s  advisable to mention  at this \point. 
The  priority subjects  are  determined by  the  Committee  for ·Prop.ri~ta·ry Medi ci!'.al 
-Products  by  agr.eement  with't"e  Pharm~ceutical Committee.  The  -nati·onal 
authorities appoint  the exp.erts  they  consider best· qualified to· take part 
\  '  .  , 
· in the  work.  ·ou.ring  the st•ge .,in  whi:ch  the project·s. art being .drawn  .~p.,_ 
·"'  ·  .• 1. 
/i, 
' '.  ~ 
''i,_  . 
. .. 
'  >,;;, 
! 
·'  ,. 
~ .  ~-' 
I  ', i 
i  : t "  I  ,, 
-:·.-
''. 
'j  .  '>  '\  :  ..... 
.  -··1-f .  ...: 
tne.a~/ ~overnment  :  .•  ~ptrtl-,~.u~  LL·~ ·contuft. v'lriO·WI 'IX~~rts 'o.•t  -~ht1 r  choi_ee  in.·  . I'  ~  - \ i. 
the- un.ivers·i-ties .or  the  ph~.rmaceutfca{  industry.--·When·a  p.rojer.t  is .considered.  ,  ... .  ) 
b; the  panel  t'o ·have  mad~' a,dequate-·pr~gress, 1t  is submitted· to the  Cornmi·t:te.e-- __,_  _ 
fo-r .. Proprietar.y Medtcirial_.Products.  Once  the  Committee  has.provis-ionatly 
'  ,  I  ,  •  - -- -
ac.cepted the t_ext · presente9, it forwards-it fof'  commer.t _to  the  national 
authorities~ who  then  -con-sult _the.  parti,es  concerned at  nati~nal. teyel. 
Simulta.neously,_  the  Commissior{  sends the project to the  repre-s-el)ta.tives  of·. 
the  ~uropean pharmaceuti~al.industr~~ The  obs~rv~ti~ns obtained are.then 
~  - •  •  '  '  •  .J 
. st~died by· t'he  panel  of experts over  a  period of  six· to ten 1non~hs_ and  a  1. 
definitive _draft  is submitted t·o  the ·committe-e  ·for--Propri~tary Medicinat 
'  . 
Products for  -ado_pti~n  .•  The  C_ommiss_ion  and,  where:  appropriate,  the  Council 
·- decide  in due  cot,Jrse  upon 'the action to b·e  taken on these  various- projects_  • 
.  I 
...... 
At  a  joint meeting  of. the experts  in the working  parties  and  experts 
representing the El.Jropean  pharmaceutical  industry ·on  10 Jvne ·1980,  a -certain 
conc_urrence  of  views·  emerged  at  the--technic~L  level'.  However,  the pharma_-- ·· 
ceuticaL  industry has.Qn  sever·at  occasions  regretted  tha~, it ha·d-·not-been 
- . 
.,. 
;.  ~  ' 
formally  consulted-when  these projects were  first being  drawn  up.  The  committee  · 
'  •  •  '  •  - < 
· has nof yet  considered  it·· advisabt·e. to ~adm-i-t  the .industry's r·epresentatives 
~to  the  worki\ng "parties. 
In  t!lE~  course o{ its work,  the ·committee  has  been  faced  with· various 
questions raised by  the "na~ional authorities .during  the 'i-mplementation of  the 
'  ' 
_provisions of  Qirectives 65/65/EEC,  75/318/EEC- and  ~5/319/EEC which  ~re· 
directly  co~nected with the  examin~tioh ~f  applicatid~s  to~  autAorization~ 
In the first  instance,  these  reflections conduce  to more  uniform  impL,-
m·entation of these Directives.  Thus  it was  that the  Committee  de·fined its 
'  ..  - -
position  regarding  the  qu~stion whether  certain preparations possessed. the 
J/ 
. charac.teristi.cs of' medi·cines -or  proprietary medi cinat products.  It has  also· 
s-tudied  the.  nation'al  requirements  for  identification of 'colouring  agents  in 
finished prod_ucts. 
1
The  work  of  t~e- pa_nels  on  safety and  efficacy .h.as  served 
','' 
_ ..  '. 
-.  to bring  closer  t()geth'er  the points of .view  _of  the national  experts. concerning· 
. the .implementati~n of  Direc-tive 75/318/EEC  as~· rega~ds pharmacological ·and  toxi'-~ · 
cological tests and  clinical trials, while  highlighting the various·dif,ferences 
of opinion. ·Further_more,  this  work  has  g,reatly fa:cilitated  t-he  adoption of the·,. 
; 
Committee's opinions on  applicatidns  submitted  ih accordance  with  th~'procedur._e 
'  \  !.  ~  '  /  ~  .  -.  -
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.• 
;  . 
·.'  ~  j 
- ...; .  -1.2  .. _, ' 
In the .medium  ter'm,  certain  domments  m1y  promp:t  th'e·  Cc~i·ssion; if -it 
considers' it  wort~;whi  te, to. ma_k·e  proposa  l_s  for  ;·~proving' the present_ 
Directi-ves; after 'consulting  the Pharmaeeutiea·L  Commi~tee.  ;. 
r  . 
\.  'J' 
.,  '  . 
·._  /  For·  it\stance., ·;t is .not  ea·sy  to  interpr-et  Art1cle--_4(B)  of Directive-
,  ~S/65/EEC, which makes· provision for  certai-n'. ~xe~pt.ions  conc~rning the ad- ·.:·-. 
mission of. the results of  ph_armaco~ogi,(al and.toxic()logical_ tests ·and  .  ·' 
_  ·ctini',cal  trials.  Some  authorities accept  an  abridged dossie-r  if the d.r49. is 
weLl  known_  .. -·The·  Commi~tee has enquired  __ about  the practices in force  i,ti  t_he · 
Member  States· be.cause  it-.ha·s ·its-elf  had  to define .its pqsition when  two 
abridged applications  submitted  in  accor.dance  with its proc~dur'e· have  been  --,  . ' 
In- addition,  the  Committee  'has  taken  note of .post"'11larketing-surveiltance: 
· ·  ..  p~ lot· projects. they. concern  clinical trials carried out  atter marketi.ng ~and' 
· intended,  in  ver~- spec-ial  cases~ to enable the  volu~e ·of  the initial .appliea-
'  :  ~ 
•  I  . '  '  \  ~  • 
~ion· f:i le. to be  reduced· in order  not  t_o  deprive patients for ·too  long -of  a 
drug  that is valuable but  exerts certain rare side•effects whi·ch_ perhaps  can 
be  detected only as a  result of a  great number  of observations. 
Finally,  the Committee  has acquainted -itself  with  the  n~w· problems 
relating to the·  testing .of  subs.tances  manufaet~red by means ·o_1  bioengine~_ring 
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. 1.: IMPORTATIONS,  en  miLliona'd'UCE,  ·r~~.t*  _Chapitre-30.03 
I  ----~~~~~-~~ 
t'  ~~~X I  67  ~  I 83.%  -z·u  87~~ 
~  I 
I 
I 
% ·intra  CEE  79  %  59  %  90. %  59  %'  '+  ,  , '4  , ,  ,  I  lo 1  " 
-
I  I  l  - .... ,__.-- _:!'  ___  ....,  ,;-r 42  .J  '  ! 
1976  1  'J31  '~~a  ~1  .,.,  1199  -230  56  ,._\.  -f  i  ,(..)  • l  ,(.  I  •  f  '  ,  l 
r  %. 'intra  CEE  72  ~  I t :)  %  I  77  %i  ;·'l  i.'  8..,  i.'  77 
~I  s9  %· I 87  % 
1 
60·%  .  ffi .  'I  '  •  I  •  I 
/0 
- ~  l 
1977  1  .. 189.  326  · 35  l-·11;  21?  240  ''143  [  ·49  l  67 
i.  intra  CEEJ  73  X . 63  X  87  %:  73  %1  84.X  76 ·Y.  65  %  97  %  -.64  % 
- I 55--:  1-!,3- ! 259  I  1978  ' 1.  44 7  410  277  168  59  "?7 
'%  intra  CEE  72 
n)'  63  %- .·  85  X .71  X  180  X  76  i.  l 




1979  '1 .648  48i  65  154  . 281  '  301 
~  210  i1  82 
78  % 72  %  '  ·  80  % I 
\ 
% intra ·cEE  72  %  65  %·  76  %  65  %  98  %  59 % 
\  . 
1980  *)  1.849  540.  101  182  296  322  231  87  90. 
% intra  CEE  72  %  63  %'  74  % 73  %  82  %  75  %  69  %  98  %  60% 
- -
··  ·  2.  £~EQB.!6.!J.Qt!§;'en millions  d'UCE,  T.o~c.  Chapitre-30.03 
'  .. 
Annee  d'ex.:.. 
., . 
po'rtation  ·  EUR  9.  DEUT.  - FR  IT  NL  B•L  UK  IREL~  OK 
,, 
~ 
I.  1975  1.  7.86  . 518  344  116  126  •' 17.1  427"  16  '79 
~ intra  CEE  33  ~  31  %  26  r.  't.7  %  1.~9  %  ·66  %  23  %  59  %  24'%  . 
1-976  .2 .-184  642  407  1_37.  179  ''220  475  . 22 ii- 100 
'  % intra  CEE  33  %  31  %  26  %  34.%  ·48  %  65 " 
21t  %  ~65  %·  .  24  %  . 
.1977  2.551  708  472  172 -·  211  266  . 573  29  \  120  . 
~  intra_CEE  ~ 33  %  28  %  28  %  30  %  51  %  63  %  ·24  %  ·72  %  24  % 
~ 
1978  2.887  768  54-6  175  232  -317  . 681  34  130' 
~  i'nt ra  CEE  36  %  29  %  32·%  . 32·%  52  % -65  %  27  ~  72  %-.  30  % 
1979.  '3 .1'36  862  649  187  .237.  334  675  . 45  147 
% int.ra  CEE  37'%  29  % .  33  %  33- %  53  %·  64  ~  34  %  71  %·  32  % 
I 
·' 
1980  *' 
3.801  992  828·  '  221  278  394  868~  49:  171 
% intra  CEE  35  %_  -~o. r.  29  % " 31  %- 52  %'  59  %  29  %  69  %  32  % 
*)  ·Chiffres provisoi_res ..  .  ' 
. \. 
·,. 
.  ... .  '  t 
'  .j  1' .. 
J  .;  . 
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- .. --.-~--- -·-.  ••  ,.,._  ~  •  -~  ....  ·~-Jo  -~ --+  - ......... :_\. 
_PROGRESS  REPORT  ON.EFFICACY  GUIDELINES 
·~·· 
1.  Subject  of  !nstrrtion to the 'Worki'n9  group,.  ·  .· 
- '  _  ---.~·  _  ~:.. Ref.,  n°  Qf, draft  a~tively p·rep .. by  working  group 
·  _- _  .  ·  ·  . ·  "t3e!  Dr  ft submitted to CPMP  · 
4e  Oraft  forwarded  to 
.  '/ 
· nat··ional  agencies -for  comments 
---,;" Redi-scussion of  co'mmen·cs  in 
.  J  t.hl  working  group 
6Qj  P.e~fsed version· before  CPMP  · 
7..  APi)roval  _by  CPMP 
8.,  Adoption ·and 
publication 
. ;·  ·~  ifxed' combina~ions. III/115/79.  01-78 
.. :.-·>-:·  ::--:  .  ,.  <ex  1387>, 
. .  Non.;..stero,_d.  III/115/79  01-78  since 
anti~inflamm.  (ex  1388)  78 
.  1'-
:.-•·:.-·.  Antiep·; teptic  III/634/?a  ._  04-78  06-78 02-so 05•ao 
-.  ·  .. ·"  ·  Card-iac  Glycos_ides  · III/635/78  11-7.8  11-78 
. :  ~ .  '  :  11-80 
•-'.  _.  ·- aioavailab1lity  Ili/573/79  11~78 06•79 
·,- ..... 
.  ~.  :  .:~  ' 
. :··A. 
-..  :.: -~·:_  ... ·.:. 
~harmacokin  .. in  man  III/1665/79 
Antiarigi~~l  ,  III/1261/78  11-78  11-78 
I  .;' 
Qr.contr.;clini.cal  l-I_I/_571/79.  02~79 06-79 P2~ao·f05-80 11-80 : ···. 
lii/572/79 ' 02-79  06-79 02;..80  05-80  11•80  .  ..  Or.contr.informat~ 
·~ .. ~. -:: :!  . . 
.  ';_.'_·:· · · ·  Ant ihyperte,~_sive 
·.··.  ,· ·  Antihyperglycaemic 
I  ...._  '  '  • 
III/1667/79. 05;..80- 5~80 ••  -.·.··~··~·--·~· ........ (OMS/~HO text> 
.-:'  ·. 
·:  '  '.  .  '  .. 
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